Valion Bio Accounts Payable

Valion Bio (VBIO) currently reports a accounts payable of $640K as of June 2026. That compares with $230K in the prior-year period — up 173.1% year over year. Use the charts on this page to explore Valion Bio's accounts payable history and peer comparisons.

Valion Bio's accounts payable increased from $230K to $640K — a 173.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Valion Bio reported $640K in accounts payable as of June 2026. That compares with $230K in the prior-year period — up 173.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $640K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Valion Bio, and consider following VBIO for alerts when major investors trade the stock.